Pharmacist Admits Filling Counterfeit Prescriptions by Selling Oxycodone and Codeine for Money | USAO-NJ

NEWARK, NJ — A pharmacist and drugstore owner pleaded guilty today to violating the controlled substances law by filling fraudulent and counterfeit prescriptions in exchange for money, U.S. Attorney Philip R. Sellinger announced.

Anthony Duncan, 61, of Hillside, New Jersey, pleaded guilty before U.S. District Judge William J. Martini in federal court in Newark to an information charging him with one count of conspiracy to distribute and possess with intend to distribute oxycodone and codeine.

According to documents filed in this case and statements made in court:

Duncan was a licensed pharmacist who owned and operated Parkway Central Pharmacy in East Orange, New Jersey. Duncan’s conspirators obtained fake prescriptions for controlled substances, including oxycodone and codeine. They brought these bogus prescriptions to Duncan at Parkway Central, who filled the prescriptions knowing they were fake or counterfeit and that he was prohibited from dispensing controlled substances without a valid prescription.

Duncan accepted cash payments from his conspirators in exchange for filling the fraudulent and counterfeit prescriptions and dispensing controlled substances. He was usually paid $4 for each 30mg oxycodone pill; $2 for each combination product of oxycodone and acetaminophen; and $10 for every eight ounces of codeine-containing cough syrup. From November 2014 to November 2018, Duncan filled over 1,100 fake or counterfeit prescriptions for controlled substances. He illegally sold to a conspirator at least 47,000 tablets of Oxycodone 30 mg; 46,000 tablets of oxycodone and acetaminophen combination product; and 56,000 milliliters of cough syrup containing codeine.

The count of conspiracy to distribute and possess with intent to distribute oxycodone and codeine is punishable by up to 20 years in prison and a fine of up to $1 million. dollars, or twice the defendant’s gross profit, whichever is greater. Sentencing is scheduled for November 8, 2022.

US Attorney Sellinger credited Drug Enforcement Administration special agents, under Special Agent in Charge Susan A. Gibson, with the investigation that led to today’s guilty plea.

The government is represented by Assistant United States Attorney Hayden M. Brockett of the Health Care Fraud Unit in Newark.

Comments are closed.